# Clinical Utility of the Alaris MidLatencyAuditoryEvoked Potentials Monitor to Titrate the Anesthetic-Hypnotic Component of Anesthesia

> **NCT00181051** · PHASE3 · SUSPENDED · sponsor: **Gustave Roussy, Cancer Campus, Grand Paris** · enrollment: 128 (—)

## Conditions studied

- Scheduled General Anesthesia

## Interventions

- **DEVICE:** Alaris AEP monitor

## Key facts

- **NCT ID:** NCT00181051
- **Lead sponsor:** Gustave Roussy, Cancer Campus, Grand Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2003-02
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 128 (—)
- **Last updated:** 2005-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00181051

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00181051, "Clinical Utility of the Alaris MidLatencyAuditoryEvoked Potentials Monitor to Titrate the Anesthetic-Hypnotic Component of Anesthesia". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00181051. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*